Annual Meeting GU 2016 Clinical trials in bladder cancer with Atezolizumab and Pembrolizumab

Matthew Galsky, MD Director of Genitourinary Medical Oncology at the Tisch Cancer Institute discusses Clinical trials in bladder cancer with Atezolizumab and Pembrolizumab at ASCO GU 2016